Back
Viking Therapeutics Vs. Pfizer Industry Stock Comparison
Sell
38
VKTX
Viking Therapeutics
Last Price:
53.43
Seasonality Move:
47.41%
Sell
26
PFE
Pfizer
Last Price:
25.76
Seasonality Move:
0.66%
Sell
38
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $51.99. The Score for VKTX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Pfizer (PFE)
is a Sell
Is Pfizer a Buy, Sell or Hold?
- The current Pfizer [PFE] share price is $26.17. The Score for PFE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- PFE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $51.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
PFE Stock Price Chart
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.12 | Sell |
| Relative Strength Index (14 RSI): | 36.59 | Sell |
| Chaikin Money Flow: | -1174197 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.31 - 71.47) | Sell |
| Bollinger Bands (100): | (54.04 - 67.18) | Sell |
PFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.86 | Sell |
| Relative Strength Index (14 RSI): | 43.1 | Sell |
| Chaikin Money Flow: | 12120258 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.64 - 28.46) | Sell |
| Bollinger Bands (100): | (27.35 - 29.99) | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.44 | Buy |
| 20-day SMA: | 60.58 | Sell |
| 50-day SMA: | 63.48 | Sell |
| 200-day SMA: | 62.33 | Sell |
| 8-day EMA: | 53.23 | Sell |
| 20-day EMA: | 57.84 | Sell |
| 50-day EMA: | 61.07 | Sell |
| 200-day EMA: | 55.55 | Sell |
PFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.33 | Buy |
| 20-day SMA: | 26.62 | Sell |
| 50-day SMA: | 28.14 | Sell |
| 200-day SMA: | 28.08 | Sell |
| 8-day EMA: | 25.68 | Buy |
| 20-day EMA: | 26.45 | Sell |
| 50-day EMA: | 27.57 | Sell |
| 200-day EMA: | 28.88 | Sell |
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.48 per share.
Pfizer Earnings Growth & PFE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.04 per share.
Viking Therapeutics Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pfizer Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||